Clinical features of ANCA-positive systemic lupus erythematosus: Report of two cases [1]

Scandinavian Journal of Rheumatology

Volumn 36, Issue 1, 2007, Pages 74-76

  Cavagna, L ^a,c   Caporali, R ^a   Esposito, C ^a   Augetti, C ^b   Epis, O ^a   Montecucco, C ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ADULT; AGED; ALOPECIA; BRAIN; CASE REPORT; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; FEMALE; HUMAN; IMMUNOASSAY; LETTER; LEUKOPENIA; LOW DRUG DOSE; MASTOIDITIS; MEMORY DISORDER; MICROANGIOPATHY; MOUTH ULCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOSENSITIVITY; POLYARTHRITIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED;

EID: 34147174401     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740600844738     Document Type: Letter

References (10)

1. Chikazawa H, Nishiya K, Matsumori A, Hashimoto K. Immunoglobulin isotypes of antimyeloperoxidase and antilactoferrin antibodies in patients with collagen disease. J Clin Immunol 2000;20:279-86.
2. Molnar K, Kovacs L, Kiss M, Dobozy A, Pokorny G. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus. Clin Exp Dermatol 2002;27:59-61.
3. Galeazzi M, Morozzi G, Sebastiani GD, Bellisai F, Marcolongo R, Cervera R, et al. Anti-neutrophil-cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European concerted action on the immunogenetics of SLE. Clin Exp Rheumatol 1998;16:541-6.
4. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
5. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004;65:521-530.
6. Pape L, Strehlau J, Latta K, Ehrich JH, Offner G. Drug-induced lupus as a cause of relapsing inflammatory disease after renal transplantation. Pediatr Transplant 2002;6:337-9.
7. Ishiyama A, Canalis RF. Otological manifestations of Churg-Strauss syndrome. Laryngoscope 2001;111:1619-24.
8. Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Am J Kidney Dis 2003;41:539-49.
9. Marshall S, Dressler R, D'Agati V. Membranous lupus nephritis with antineutrophil cytoplasmic antibody associated segmental necrotizing and crescentic glomerulonephritis. Am J Kidney Dis 1997;29:119-24.
10. Arahata H, Migita K, Izumoto H, Miyashita T, Munakata H, Nakamura H, et al. Successful treatment of rapidly progressive lupus nephritis associated with anti-MPO antibodies by intravenous immunoglobulins. Clin Rheumatol 1999;18:77-81.